These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27134062)

  • 1. Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk.
    Bozzetto L; Annuzzi G; Ragucci M; Di Donato O; Della Pepa G; Della Corte G; Griffo E; Anniballi G; Giacco A; Mancini M; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):623-629. PubMed ID: 27134062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
    Chellali S; Boudiba A; Griene L; Koceir EA
    Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphenol-rich diets improve glucose metabolism in people at high cardiometabolic risk: a controlled randomised intervention trial.
    Bozzetto L; Annuzzi G; Pacini G; Costabile G; Vetrani C; Vitale M; Griffo E; Giacco A; De Natale C; Cocozza S; Della Pepa G; Tura A; Riccardi G; Rivellese AA
    Diabetologia; 2015 Jul; 58(7):1551-60. PubMed ID: 25906754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
    Yamaoka-Tojo M; Tojo T; Takahira N; Matsunaga A; Aoyama N; Masuda T; Izumi T
    Cardiovasc Diabetol; 2010 May; 9():17. PubMed ID: 20470376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on "Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk".
    Sani M; Ayubi E
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):90-91. PubMed ID: 28061944
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply from the authors to "Comments on 'Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk'".
    Annuzzi G; Bozzetto L; Mancini M; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):91-92. PubMed ID: 27914695
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
    Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome.
    Giacco R; Costabile G; Della Pepa G; Anniballi G; Griffo E; Mangione A; Cipriano P; Viscovo D; Clemente G; Landberg R; Pacini G; Rivellese AA; Riccardi G
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):837-44. PubMed ID: 24598599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome.
    Vetrani C; Costabile G; Luongo D; Naviglio D; Rivellese AA; Riccardi G; Giacco R
    Nutrition; 2016 Feb; 32(2):217-21. PubMed ID: 26706023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 response to sequential mixed meals: influence of insulin resistance.
    Rebelos E; Astiarraga B; Bizzotto R; Mari A; Manca ML; Gonzalez A; Mendez A; Martinez CA; Hurwitz BE; Ferrannini E
    Clin Sci (Lond); 2017 Dec; 131(24):2901-2910. PubMed ID: 29097626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.